MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
2023: Top 20 Genomics Companies in the World
Editas Medicine, Inc. (NASDAQ:EDIT)*
Finance & Acquisitions: Editas
Parents
Editas Medicine, Inc. (NASDAQ:EDIT)*
Children
2013: Editas Medicine gets $43M round to edit illness out of the genome (2013)
2016: Editas biotech stock drops by 26 percent over CRISPR patent dispute
2019: Editas and BlueRock join forces
2019: Editas Medicine (EDIT) Investor Presentation - Slideshow_seekingalpha.com
2023: After long-running patent battle, Vertex pays $100M to license Editas’ gene-editing tech
2023: Editas Medicine, Inc. (NASDAQ:EDIT)
2024: Editas lays off 65% of staff, including CMO, after fruitless search for reni-cel partner
Editas Medicine Inc Stock Quote: EDIT Stock News, Quotes, Analysis
Editas Medicine_Crunchbase
Editas Medicine, Inc. (EDIT) Analyst Research
Flagship Ventures, Polaris Partners Third Rock Ventures and participation from Partners Innovation Fund contributed to the Series A round.
Revenue (2018): $32 million
Revenue (2019): $20.5 million
Jumps
*Key People: Editas
Organization & Developments: Editas